Source:http://linkedlifedata.com/resource/pubmed/id/10570324
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0022688,
umls-concept:C0085862,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0225336,
umls-concept:C0382839,
umls-concept:C1135183,
umls-concept:C1299583,
umls-concept:C1415585,
umls-concept:C1415587,
umls-concept:C1549571,
umls-concept:C1608386,
umls-concept:C1704259,
umls-concept:C1705987,
umls-concept:C2911684
|
pubmed:issue |
11
|
pubmed:dateCreated |
1999-12-20
|
pubmed:abstractText |
Human NK cells contribute a significant role to host defense as well as xenogeneic cytotoxicity. Previous studies using human 721.221 cell line have shown that peptides derived from the leader sequence of the HLA-G binds and up-regulates the surface expression of HLA-E molecules, which was considered to consequently provide negative signals to human NK cells. However, the direct role of HLA-G in inhibiting human NK cells remains controversial. In this study, we showed that the expression of HLA-G or HLA-E in porcine endothelial cells directly protected sensitive porcine cells from human NK cell-mediated xenogeneic cytotoxicity. Ab blocking assays using F(ab')2 of the HLA class I-specific mAb PA2.6 indicated that the protection was directly mediated by the expression of HLA-G and HLA-E on the porcine cells. The HLA-E-mediated protection was blocked by anti-human CD94 Ab. In addition, the engagement of HLA-E lead to the phosphorylation of the CD94/NKG2 complex and the recruitment of SH2 domain-containing protein phosphatase 1 (SHP-1) to the complex. Therefore, HLA-E protected porcine cells from xenoreactive human NK cells through a CD94/NKG2-dependent pathway. In contrast, HLA-G inhibited human NK cells in the absence of CD94/NKG2 phosphorylation or SHP-1 recruitment, and the inhibition was not blocked by anti-CD94 Ab. Therefore, HLA-G protected porcine cells from human NK cells through a CD94/NKG2-independent pathway. These results demonstrated that both HLA-E and HLA-G could directly inhibit human NK cells in the absence of other endogenous HLA class I molecules. These results also have practical implications in preventing xenograft rejection mediated by human NK cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Heterophile,
http://linkedlifedata.com/resource/pubmed/chemical/HLA Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-E antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-G Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
163
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6301-5
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10570324-Animals,
pubmed-meshheading:10570324-Antigens, Heterophile,
pubmed-meshheading:10570324-Aorta,
pubmed-meshheading:10570324-Cytotoxicity, Immunologic,
pubmed-meshheading:10570324-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:10570324-Endothelium, Vascular,
pubmed-meshheading:10570324-HLA Antigens,
pubmed-meshheading:10570324-HLA-G Antigens,
pubmed-meshheading:10570324-Histocompatibility Antigens Class I,
pubmed-meshheading:10570324-Humans,
pubmed-meshheading:10570324-Killer Cells, Natural,
pubmed-meshheading:10570324-Recombinant Proteins,
pubmed-meshheading:10570324-Swine
|
pubmed:year |
1999
|
pubmed:articleTitle |
HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways.
|
pubmed:affiliation |
Departments ofSurgery and Pathology, Washington University School of Medicine, St. Louis, MO 63110, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|